⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14455200 | 1.00 | — | — | |
| SCHEMBL1354775 | 0.84 | — | — | |
| SCHEMBL18107307 | 0.82 | — | — | |
| SCHEMBL15298848 | 0.82 | — | — | |
| SCHEMBL17677721 | 0.79 | ALDH1A1 (0.32) | — | |
| SCHEMBL18107199 | 0.78 | — | — | |
| SCHEMBL10140982 | 0.78 | — | — | |
| SCHEMBL16440243 | 0.78 | — | — | |
| SCHEMBL10140999 | 0.78 | — | — | |
| SCHEMBL127400 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11760765-B2 | Method for producing triarylorganoborates | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2023-09-19 | — | — | US | disclosed |
| WO-2023098656-A1 | COMPOUNDS FOR THE DEGRADATION OF EGFR KINASE | BEIGENE, LTD. (GB) | 2023-06-08 | — | — | WO | disclosed |
| US-20230045848-A1 | THERMOSETTING RESIN COMPOSITION AND PREPREG, LAMINATE AND PRINTED CIRCUIT BOARD USING SAME | SHENGYI TECHNOLOGY CO., LTD. (CN) | 2023-02-16 | — | — | US | disclosed |
| WO-2022012622-A1 | DEGRADATION OF (EGFR) BY CONJUGATION OF EGFR INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE | BEIGENE, LTD. (KY) | 2022-01-20 | — | — | WO | disclosed |
| US-20220002321-A1 | METHOD FOR PRODUCING TRIARYLORGANOBORATES | COVESTRO DEUTSCHLAND AG (DE) | 2022-01-06 | — | — | US | disclosed |
| WO-2020159183-A1 | POLYIMIDE-BASED POLYMER FILM, AND SUBSTRATE FOR DISPLAY DEVICE AND OPTICAL DEVICE, EACH USING SAME | 주식회사 엘지화학 | 2020-08-06 | — | — | WO | disclosed |
| WO-2020159174-A1 | POLYIMIDE-BASED POLYMER FILM, AND SUBSTRATE FOR DISPLAY DEVICE AND OPTICAL DEVICE, EACH USING SAME | 주식회사 엘지화학 | 2020-08-06 | — | — | WO | disclosed |
| US-9738738-B2 | Polymers functionalized with activated nitrogen heterocycles containing a pendant functional group | BRIDGESTONE CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| EP-2753364-B1 | A CONDITIONAL REPLICATING CYTOMEGALOVIRUS AS A VACCINE FOR CMV | MERCK SHARP & DOHME (US) | 2017-05-24 | — | — | EP | disclosed |
| US-9609861-B2 | Platelet additive solution having a β-galactosidase inhibitor | VELICO MEDICAL INC. (US) | 2017-04-04 | — | — | US | disclosed |
| WO-2016205646-A1 | FILM STRUCTURE AND BALLOON INCLUDING THE SAME | HARLOW HARRY (US) | 2016-12-22 | — | — | WO | disclosed |
| US-20160289355-A1 | POLYMERS FUNCTIONALIZED WITH ACTIVATED NITROGEN HETEROCYCLES CONTAINING A PENDANT FUNCTIONAL GROUP | BRIDGESTONE CORPORATION (JP) | 2016-10-06 | — | — | US | disclosed |
| US-8092833-B2 | Compositions containing inclusion complexes | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2012-01-10 | — | — | US | disclosed |
| US-20110206668-A1 | METHODS AND COMPOSITIONS FOR MODULATING IMMUNITY | TRILLIUM THERAPEUTICS INC. (CA) | 2011-08-25 | — | — | US | disclosed |
| US-20110182864-A1 | COMPOSITIONS CONTAINING INCLUSION COMPLEXES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2011-07-28 | — | — | US | disclosed |
| US-7902151-B2 | Methods and compositions for modulating immunity | TRILLIUM THERAPEUTICS INC. (CA) | 2011-03-08 | — | — | US | disclosed |
| US-7553811-B2 | Methods and compositions for modulating immunity | TRILLIUM THERAPEUTICS INC. (CA) | 2009-06-30 | — | — | US | disclosed |